瓦尔酸盐通过降低myo-inositol-3-phosphate合成酶的表达来调节内醇合成
Kendall C Case1, Rachel J Beltman2, Mary Kay H Pflum2
1Department of Biological Sciences, Wayne State University, Detroit, MI, 48202, USA.
Scientific reports
|September 8, 2023
概括
瓦尔酸盐 (VPA) 可能不会通过酸化myo-inositol-3-phosphate合成酶 (MIPS) 来稳定情绪. 相反,VPA似乎通过降低MIPS基因和蛋白质表达来减少内醇枯竭.
科学领域:
- 生物化学 生化学
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 伊诺西托尔耗尽是双相情绪障碍情绪稳定剂的拟议机制.
- 酸 (VPA) 以前被认为可以通过酸化myo-inositol-3-phosphate合成酶 (MIPS) 来降低内醇.
研究的目的:
- 调查MIPS酸化在VPA的作用机制中的作用.
- 为了识别与MIPS相互作用的蛋白激酶.
主要方法:
- 在对VPA的反应中量化MIPS酸化水平.
- 使用相互作用屏幕来识别MIPS相互作用的激酶.
- 在VPA治疗后分析MIPS mRNA和蛋白质水平.
主要成果:
- 发现VPA对MIPS的酸化是最小的 (少于2%).
- 在体外,PKC和CKII对MIPS的特异性较低.
- VPA显著降低了INO1 mRNA和MIPS蛋白质水平.
结论:
- VPA可能通过MIPS酸化以外的其他机制消耗伊诺西.
- 通过降低MIPS酶的表达,VPA降低了内醇水平.
相关概念视频
Phosphoinositides and PIPs
8.6K
Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
8.6K
Antiepileptic Drugs: GABAergic Pathway Potentiators
452
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
452
Feedback Inhibition
54.0K
Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
54.0K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
559
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
559
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
339
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
339
IP3/DAG Signaling Pathway
12.2K
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
12.2K


